Live Oak Health Sciences Fund (LOGSX)

21.82
Net Asset Value
+0.37%
1 Day
+6.34%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
No Load
Sales Expenses
1.12%
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital growth. The fund invests primarily in common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. It will invest at least 80% of its net assets, under normal circumstances, in equity securities of health sciences companies. The fund invests primarily in common stocks of U.S. companies, but may, to a lesser extent, invest in common stocks of foreign companies and American Depositary Receipts ("ADRs") that meet the investment criteria of the fund.

Performance

1 month+2.35% 3 years+24.12%
3 months+4.14% 5 years+18.85%
1 year+20.04% Since inception+8.41%
Data through --

Peer Comparisonvs. Health

 LOGSXCategory
Performance 5-yr return+18.85%+21.57%
Expense ratio1.12%1.45%
Risk 5 year sharpe ratio1.581.52
Net assets$54.5M$3.7B
Average market cap$30.1B$35.3B
Average P/E23.126.2
Portfolio turnover15%15%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyOak Associates
Fund manager & tenureMark Oelschlager / 13 Years
Minimal initial investment$2,000.00
Minimum IRA investment--

Holdings

U.S. stock82.20%
International stock14.72%
Cash3.07%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 95.95%
Consumer service 4.05%
Business service 0.00%
Consumer goods 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
BCR C R Bard Inc6.07%
CAH Cardinal Health Inc6.07%
AMGN Amgen4.91%
BDX Becton Dickinson and Co4.42%
-- 4.13%
MRK Merck3.85%
ANTM WellPoint3.82%
TEVA Teva Pharmaceutical3.78%
AZN AstraZeneca3.78%
WAT Waters Corp3.21%

To view my watchlist

Not a member yet?

Sign up now for a free account